Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology. He's seen here at a Sept. 4, 2025, hearing before the Senate Finance ...
Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...
Rapid growth in infectious disease and cancer immunotherapy applications; Lipid nanoparticles lead delivery methods, while polymeric carriers are expected to grow rapidly.Austin, Oct. 28, 2025 (GLOBE ...
NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...
Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...
Former Surgeon General Jerome Adams — who served during the first Trump administration — argued Sunday that "people are going to die" if the U.S. backs away from mRNA vaccine development, after ...
WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...
Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m in the 2025's year to date (YTD), according to GlobalData’s Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback